This week, the Food and Drug Administration (FDA) warned of a voluntary recall of brand allergy medication Zyrtec from manufacturer Drugmaker Unique Pharmaceutical Laboratories due to possible contamination.

According to the health entity's statement, the antihistamine medication (cetirizine hydrochloride USP 5 mg) was cross-contaminated with a heartburn medication (ranitidine), which could cause side effects in consumers sensitive to the ingredients contained in ranitidine; Even exposure to the drug could cause hypotension, loss of consciousness, among others.

According to details of the report, the seasonal allergy medication was distributed by Rising Pharma Holdings Inc. to several retail chains in the country, in bottles of 100 tablets with lot numbers GY825029, GY825030, GY825031, GY825032 and an expiration date of October 2028.

To date, no cases of poisoning have been reported in the consumption of this medication; However, the FDA warns about the danger of ingesting it if you are allergic to ranitidine, so it is recommended to discard it or return it to the store where you purchased it for a refund.

For its part, Rising Pharma Holdings reported that consumers with further questions about the recall can contact it at 1-844-874-7464 or by email at pv@risingpharma.com or qa@risingpharma.com.